Back to 
Two Sigma Advisers, LP
Two Sigma Advisers, LP
PTGX
Showing 2 of 25 quarters
Position history for Two Sigma Advisers, LP's holdings in Protagonist Therapeutics, Inc.
No. Two Sigma Advisers exited its PTGX position in Q4 2024. Its Q3 2024 13F listed 12,100 shares worth $544,500. Two Sigma Advisers already held PTGX in its Q4 2018 13F, the earliest on record, and held it in 24 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$544,500
Total Shares Change
-12,100
Quarter-by-Quarter History